Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 7472

BillFederalHouseIn Committee
To amend the Federal Food, Drug, and Cosmetic Act to grant eligible researchers access to eligible products at a discounted price for qualified research, and for other purposes.
About This Bill
Committee
Latest Action · April 8, 2022
Referred to the Subcommittee on Health.
Congress
117th (2021–2023)
Introduced
April 7, 2022
Cosponsors (5)
5D 0R
View PDF ↗

Summary

Highlight any text to annotate
Discounted Drugs for Clinical Trials Act This bill allows researchers to obtain certain high-cost drugs and biologics at discounted prices from manufacturers. Researchers must apply to the Food and Drug Administration for approval; manufacturers must sell the approved quantity of drugs to researchers at the discounted price and are subject to civil actions from researchers for noncompliance.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.